YORK, Oct. 12, 2022 /PRNewswire/ -- The Gross
Law Firm issues the following notice to shareholders of Ampio
Shareholders who purchased shares of AMPE during the class
period listed are encouraged to contact the firm regarding possible
lead plaintiff appointment. Appointment as lead plaintiff is not
required to partake in any recovery.
CONTACT US HERE:
CLASS PERIOD: This lawsuit is on behalf of all persons or
entities that purchased or otherwise acquired Ampio common stock
between December 29, 2020 and
August 3, 2022, inclusive.
ALLEGATIONS: The complaint alleges that during the class
period, Defendants issued materially false and/or misleading
statements and/or failed to disclose that: (i) defendants had
inflated the Company's true ability to successfully file a
Biologics License Application ("BLA") for Ampion; (ii) defendants
had inflated the results of the AP-013 study and the timing of
unblinding the data from the AP-013 study; and (iii) as a result of
the foregoing, defendants' statements about the Company's business,
operations, and prospects were materially misleading and/or lacked
a reasonable basis.
DEADLINE: October 17, 2022
Shareholders should not delay in registering for this class action.
Register your information here:
NEXT STEPS FOR SHAREHOLDERS: Once you register as a
shareholder who purchased shares of AMPE during the timeframe
listed above, you will be enrolled in a portfolio monitoring
software to provide you with status updates throughout the
lifecycle of the case. The deadline to seek to be a lead plaintiff
is October 17, 2022. There is no cost
or obligation to you to participate in this case.
WHY GROSS LAW FIRM? The Gross Law Firm is nationally
recognized class action law firm, and our mission is to protect the
rights of all investors who have suffered as a result of deceit,
fraud, and illegal business practices. The Gross Law Firm is
committed to ensuring that companies adhere to responsible business
practices and engage in good corporate citizenship. The firm seeks
recovery on behalf of investors who incurred losses when false
and/or misleading statements or the omission of material
information by a company lead to artificial inflation of the
company's stock. Attorney advertising. Prior results do not
guarantee similar outcomes.
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Phone: (646) 453-8903
SOURCE The Gross Law Firm